12-MONTH TREATMENT, COMPARED TO 6-MONTH TREATMENT, DOES NOT IMPROVE THE EFFICACY OF ALPHA-INTERFERON IN NANB CHRONIC ACTIVE HEPATITIS

被引：0
|
作者：
METREAU, JM [1 ]
CALMUS, Y [1 ]
POUPON, R [1 ]
JOUANOLLE, H [1 ]
MIGUET, JP [1 ]
BRECHOT, C [1 ]
CALES, P [1 ]
RAMPAL, P [1 ]
TRAN, A [1 ]
BEAUGRAND, M [1 ]
CAPRON, JP [1 ]
ZARSKI, P [1 ]
DOFFOEL, M [1 ]
PARIENTE, EA [1 ]
LEMONNIER, C [1 ]
DHUMEAUX, D [1 ]
机构：
[1] HOP HENRI MONDOR,F-94010 CRETEIL,FRANCE
来源：
HEPATOLOGY | 1991年 / 14卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A72 / A72
页数：1
相关论文
共 50 条
  • [1] INTERFERON TREATMENT OF CHRONIC ACTIVE HEPATITIS-B - EFFECT OF A 6-MONTH TREATMENT REGIMEN
    RAPTOPOULOU, M
    ORPHANOU, H
    VRETTOU, H
    AKRIBIADIS, E
    CHADZIKONSTANTINOU, L
    GOULIS, G
    GUT, 1993, 34 (02) : S102 - S103
  • [2] HIGHER EFFICACY OF 12 THAN 6 MONTH ALPHA-INTERFERON THERAPY IN CHRONIC HEPATITIS-C
    IDEO, G
    BELLOBUONO, A
    BELLATI, G
    TEMPINI, S
    LEANDRO, G
    HEPATOLOGY, 1994, 19 (04) : I75 - I75
  • [3] Treatment of HBeAg-negative chronic hepatitis B with sequential lamivudine and interferon of 12-month duration and a 6-month overlap: Preliminary results
    Manesis, EK
    Papatheodoridis, GV
    Alexopoulou, A
    HEPATOLOGY, 2002, 36 (04) : 641A - 641A
  • [4] A histopathological study of the effects of 6-month versus 12-month interferon alpha-2b therapy in chronic hepatitis C
    Ziol, M
    VanNhieu, JT
    RoudotThoraval, F
    Metreau, JM
    Deugnier, Y
    Dhumeaux, D
    Zafrani, ES
    JOURNAL OF HEPATOLOGY, 1996, 25 (06) : 833 - 841
  • [5] Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: A multicenter, controlled, randomized trial
    Payen, JL
    Izopet, J
    Galindo-Migeot, V
    Lauwers-Cances, V
    Zarski, JP
    Seigneurin, JM
    Dussaix, E
    Voigt, JJ
    Selves, J
    Barange, K
    Puel, J
    Pascal, JP
    HEPATOLOGY, 1998, 28 (06) : 1680 - 1686
  • [6] Efficacy and tolerance of a 6-month treatment course of daily interferon-alpha 2a for chronic hepatitis C with cirrhosis
    Cooksley, WGE
    McIvor, C
    Watson, K
    Smith, B
    Jackson, P
    Brotodihardjo, A
    Farrell, GC
    Jones, DB
    Ngu, M
    McCaughan, GW
    OBrien, E
    Kavanagh, J
    Morrow, AW
    Dudley, F
    Cromie, S
    Jenkins, P
    Harley, H
    Shaw, D
    Batey, RG
    Crewe, E
    Bowden, S
    Locarnini, S
    Cunningham, A
    JOURNAL OF VIRAL HEPATITIS, 1997, 4 (05) : 317 - 323
  • [7] TREATMENT OF CHRONIC NANB AND NANC HEPATITIS WITH ALPHA-INTERFERON - A METAANALYSIS OF DOSE AND DURATION
    NIEDERAU, C
    HEINTGES, T
    HAUSSINGER, D
    HEPATOLOGY, 1995, 22 (04) : 185 - 185
  • [8] INTENSIVE 6-MONTH COURSE OF INTERFERON TREATMENT FOR CHRONIC HEPATITIS-C AND CIRRHOSIS
    FARRELL, GC
    COOKSLEY, WGE
    DUDLEY, FJ
    WATSON, K
    HEPATOLOGY, 1995, 22 (04) : 46 - 46
  • [9] The sustained 6-month efficacy of eszopiclone in the treatment of chronic insomnia
    Krystal, AD
    Walsh, JK
    Laska, E
    Caron, J
    Amato, DA
    Wessel, TC
    Roth, T
    SLEEP, 2004, 27 (02) : 346 - 347
  • [10] Treatment of HBeAg-negative chronic hepatitis B (CHBe-) with sequential lamivudine (LAM) and interferon-alfa (IFN) courses of 12-month duration and a 6-month overlap
    Manesis, EK
    Papatheodoridis, GV
    Alexopoulou, A
    JOURNAL OF HEPATOLOGY, 2003, 38 : 152 - 153
12345